8-KLeadership Changes

STRYKER CORP 8-K Report, Executive Changes (Aug 2, 2017)

Filed August 2, 2017For Securities:SYK

Summary

Stryker Corporation (SYK) announced on August 1, 2017, the election of Mary K. Brainerd to its Board of Directors, effective as of July 31, 2017. Ms. Brainerd brings extensive experience in the healthcare industry, having most recently served as president and chief executive officer of HealthPartners, a large non-profit health care organization, for 15 years. Her background includes leadership roles across various healthcare entities and experience on other public company boards, which should provide valuable strategic oversight for Stryker. As a new non-employee director, Ms. Brainerd will receive compensation in line with Stryker's standard director pay practices, including annual fees and equity awards. Notably, the filing discloses that Stryker sells products to HealthPartners in the ordinary course of business, with approximately $17 million in sales between January 1, 2016, and May 31, 2017. This disclosure is important for transparency regarding potential related-party transactions, although it appears to be within normal business operations.

Key Highlights

  • 1Mary K. Brainerd elected to the Board of Directors.
  • 2Ms. Brainerd has 15 years of experience as president and CEO of HealthPartners, a major non-profit healthcare organization.
  • 3Her background includes executive roles in healthcare and prior board experience with other public companies (Possis Medical, SurModics).
  • 4Ms. Brainerd will receive standard non-employee director compensation, including annual fees and equity awards (stock options and RSUs).
  • 5She received an initial equity award including 3,005 stock options and 600 restricted stock units.
  • 6The filing discloses ordinary course business sales from Stryker to HealthPartners totaling approximately $17 million from Jan 2016 to May 2017.
  • 7There are no undisclosed arrangements or understandings related to Ms. Brainerd's selection.

Frequently Asked Questions

Mary K. Brainerd is a newly elected member of Stryker's Board of Directors. She brings significant experience from the healthcare sector, having served as the president and chief executive officer of HealthPartners, a large non-profit healthcare organization, for 15 years. She has also held executive roles with Blue Cross and Blue Shield of Minnesota and has prior experience serving on the boards of other public companies.

As a non-employee director, Ms. Brainerd will receive compensation consistent with Stryker's existing practices. This includes an annual cash fee and potentially additional fees for committee service. She will also receive equity awards, which for her initial appointment included stock options and restricted stock units.

The filing discloses that Stryker sells products to HealthPartners in the ordinary course of business, with approximately $17 million in sales between January 1, 2016, and May 31, 2017. While this represents a related-party transaction, it is disclosed as occurring in the normal course of business and does not appear to present a significant conflict, as Ms. Brainerd is a non-employee director and compensation is standard.

Ms. Brainerd's election adds a director with deep operational and executive experience in the healthcare industry. Her leadership background and experience on other boards are expected to enhance the Board's strategic oversight and governance capabilities, particularly relevant for a company like Stryker operating within the healthcare ecosystem.